Genes encoding Pir51, Beclin 1, RbAp48 and aldolase b are up or down-regulated in human primary hepatocellular carcinoma
- PMID: 14966907
- PMCID: PMC4716970
- DOI: 10.3748/wjg.v10.i4.509
Genes encoding Pir51, Beclin 1, RbAp48 and aldolase b are up or down-regulated in human primary hepatocellular carcinoma
Abstract
Aim: To reveal new tumor markers and target genes from differentially expressed genes of primary tumor samples using cDNA microarray.
Methods: The (33 )P labeled cDNAs were synthesized by reverse transcription of message RNA from the liver cancerous tissue and adjacent non-cancerous liver tissue from the same patient and used to hybridize to LifeGrid 1.0 cDNA microarray blot containing 8400 known and unique human cDNA gene targets, and an expression profile of genes was produced in one paired human liver tumor tissue. After a global analysis of gene expression of 8400 genes, we selected some genes to confirm the differential expression using Northern blot and RT-PCR.
Results: Parallel analysis of the hybridized signals enabled us to get an expression profile of genes in which about 500 genes were differentially expressed in the paired liver tumor tissues. We identified 4 genes, the expression of three (Beclin 1, RbAp48 and Pir51) were increased and one (aldolase b) was decreased in liver tumor tissues. In addition, the expression of these genes in 6 hepatoma cell lines was also showed by RT-PCR analysis.
Conclusion: cDNA microarray permits a high throughput identification of changes in gene expression. The genes encoding Beclin 1, RbAp48, Pir51 and aldolase b are first reported that may be related with hepatocarcinoma.
Figures



Similar articles
-
Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma.Cancer Res. 2001 Apr 1;61(7):3176-81. Cancer Res. 2001. PMID: 11306505
-
Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.Hepatogastroenterology. 2004 Mar-Apr;51(56):515-25. Hepatogastroenterology. 2004. PMID: 15086194
-
Expression of cell cycle/growth regulator genes in human hepatocellular carcinoma and adjacent normal liver tissues.Oncol Rep. 2003 Nov-Dec;10(6):1771-5. Oncol Rep. 2003. PMID: 14534694
-
Gene expression profiles of hepatoma cell line BEL-7402.Hepatogastroenterology. 2003 Sep-Oct;50(53):1496-501. Hepatogastroenterology. 2003. PMID: 14571772
-
Differential gene expression in human hepatocellular carcinoma Hep3B cells induced by apoptosis-related gene BNIPL-2.World J Gastroenterol. 2004 May 1;10(9):1286-91. doi: 10.3748/wjg.v10.i9.1286. World J Gastroenterol. 2004. PMID: 15112343 Free PMC article.
Cited by
-
Proteomic analysis of differentially expressed proteins in peripheral cholangiocarcinoma.Cancer Microenviron. 2010 Jun 26;4(1):73-91. doi: 10.1007/s12307-010-0047-2. Cancer Microenviron. 2010. PMID: 21505563 Free PMC article.
-
Unraveling the Janus-Faced Role of Autophagy in Hepatocellular Carcinoma: Implications for Therapeutic Interventions.Int J Mol Sci. 2023 Nov 13;24(22):16255. doi: 10.3390/ijms242216255. Int J Mol Sci. 2023. PMID: 38003445 Free PMC article. Review.
-
Partial Beclin 1 silencing aggravates doxorubicin- and Fas-induced apoptosis in HepG2 cells.World J Gastroenterol. 2006 May 14;12(18):2895-900. doi: 10.3748/wjg.v12.i18.2895. World J Gastroenterol. 2006. PMID: 16718815 Free PMC article.
-
RAD51AP1 and RAD54L Can Underpin Two Distinct RAD51-Dependent Routes of DNA Damage Repair via Homologous Recombination.Front Cell Dev Biol. 2022 May 16;10:866601. doi: 10.3389/fcell.2022.866601. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35652094 Free PMC article.
-
RBBP4 downregulation increases the sensitivity of A549 and HeLa cells to cisplatin by inhibiting cyclin D1 expression.Clinics (Sao Paulo). 2025 Apr 4;80:100637. doi: 10.1016/j.clinsp.2025.100637. eCollection 2025. Clinics (Sao Paulo). 2025. PMID: 40187236 Free PMC article.
References
-
- Chen CJ, Yu MW, Liaw YF. Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol. 1997;12:S294–S308. - PubMed
-
- Naka T, Toyota N, Kaneko T, Kaibara N. Protein expression of p53, p21WAF1, and Rb as prognostic indicators in patients with surgically treated hepatocellular carcinoma. Anticancer Res. 1998;18:555–564. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases